相关实验视频

Updated: Jul 26, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

针对针对NF-B信号通路的一些基于pyrazolone的生物活性配体的分子对接和模拟研究

Surya Philip¹, D R Sherin², T K Manoj Kumar²

¹Department of Chemistry, Mar Thoma College, Tiruvalla, Kerala, 689103, India. suryaphilip84@gmail.com.

Molecular diversity

|June 20, 2023

概括

研究人员开发了针对NF-κB通路的新型pyrazolone化合物,以对抗癌症. 一种化合物,APAU,对MCF-7细胞表现出强烈的抗癌活性,提供了潜在的治疗策略.

科学领域:

药用化学医学化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

核因子kappa B (NF-κB) 信号传递是包括癌症在内的生理和病理过程的关键调节者.
非正规的NF-κB通路与癌细胞化学抵抗有关,突出显示NF-κB是潜在的治疗标.
准NF-κB提供了一种修改瘤细胞行为和克服治疗耐药性的策略.

研究的目的:

设计和合成基于pyrazolone的新型配体,具有潜在的NF-κB抑制活性.
为了评估这些合成化合物的抗癌性质.
研究作用机制,特别是针对NF-κB信号通路.

主要方法:

一系列基于pyrazolone的生物活性联结物的合成.
使用虚拟选技术进行药理学选.
在体外抗癌试验 (例如,针对MCF-7细胞的IC50测定).
分子对接和分子动力学模拟以阐明结合相互作用和途径准.

主要成果:

合成的pyrazolones被评估为它们的潜力,以准NF-κB途径.
化合物APAU对MCF-7细胞表现出显著的抗癌活性,IC50值为30μg/ml.
分子对接证实,pyrazolones通过向NF-κB信号通路来抑制细胞增殖.
分子动力学模拟表明,基于皮拉佐的配体具有良好的稳定性和灵活性.

结论:

基于Pyrazolone的配体代表了针对NF-κB通路的有希望的化合物类别.
APAU表现出强大的抗癌作用,表明其作为癌症治疗治疗剂的潜力.
这些发现支持开发NF-κB抑制剂用于癌症治疗,特别是用于耐化学性瘤.

关键词:

这是一种抗癌药物.这是一种抗皮林的药物.印度尔 (Indole) 是一种模拟MD的模拟方法分子对接是分子对接.在NFκB信号通路中.这是一种Pyrazolone.

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...